Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Wallace, Daniel J. [1 ]
Furie, Richard [2 ]
Tanaka, Yoshiya [3 ]
Kalunian, Kenneth C. [4 ]
Mosca, Marta [5 ]
Petri, Michelle [6 ]
Dorner, Thomas [7 ,8 ]
Cardiel, Mario H. [9 ]
Bruce, Ian N. [10 ]
Gomez, Elisa [11 ]
DeLozier, Amy M. [11 ]
Janes, Jonathan [11 ]
Linnik, Matthew D. [11 ]
de Bono, Stephanie [11 ]
Silk, Maria E. [11 ]
Hoffman, Robert W. [11 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA
[2] Zucker Sch Med Hofstra Northwell, Div Rheumatol, Great Neck, NY USA
[3] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[4] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[5] Univ Pisa, Pisa, Italy
[6] Johns Hopkins Univ, Sch Med, Med Rheumatol, Baltimore, MD USA
[7] Charite Univ Med Berlin, Berlin, Germany
[8] Deutsch Rheumaforschungszentrum DRFZ, Berlin, Germany
[9] Ctr Invest Clin Morelia SC, Morelia, Michoacan, Mexico
[10] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Ctr Musculoskeletal Res, Manchester, Lancs, England
[11] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
970
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus Results of a phase I, placebo-controlled, double-blind, dose-escalation study
    McBride, Jacqueline M.
    Jiang, Jenny
    Abbas, Alexander R.
    Morimoto, Alyssa
    Li, Jing
    Maciuca, Romeo
    Townsend, Michael
    Wallace, Daniel J.
    Kennedy, William P.
    Drappa, Jorn
    ARTHRITIS AND RHEUMATISM, 2012, 64 (11): : 3666 - 3676
  • [32] PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Merrill, Joan
    June, Joshua
    Koumpouras, Fotios
    Machua, Wambui
    Khan, Mohammad Faisal
    Askanase, Anca
    Khosroshahi, Arezou
    Sheikh, Saira
    James, Judith A.
    Guthridge, Joel
    Rathi, Gaurav
    Burington, Bart
    Foster, Paul
    Zack, Debra
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 761 - 762
  • [33] Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM)
    Maurer, M.
    Elberink, H. O.
    Gotlib, J.
    Sabato, V.
    Hartmann, K.
    Broesby-Olsen, S.
    Castells, M.
    Deininger, M. W.
    Heaney, M. L.
    George, T. I.
    Siebenhaar, F.
    Radia, D.
    Triggiani, M.
    van Daele, P.
    Deangelo, D. J.
    Schmidt-Kittler, O.
    Lin, H. -M.
    Morrison, A.
    Mar, B.
    Akin, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 77 - 77
  • [34] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Askanase, Anca D.
    Zhao, Enxu
    Zhu, Julie
    Bilyk, Roman
    Furie, Richard A.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 893 - 908
  • [35] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Anca D. Askanase
    Enxu Zhao
    Julie Zhu
    Roman Bilyk
    Richard A. Furie
    Rheumatology and Therapy, 2020, 7 : 893 - 908
  • [36] A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
    van Vollenhoven, RF
    Park, JL
    Genovese, MC
    West, JP
    McGuire, JL
    LUPUS, 1999, 8 (03) : 181 - 187
  • [37] Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
    Clowse, Megan E. B.
    Wallace, Daniel J.
    Furie, Richard A.
    Petri, Michelle A.
    Pike, Marilyn C.
    Leszczynski, Piotr
    Neuwelt, C. Michael
    Hobbs, Kathryn
    Keiserman, Mauro
    Duca, Liliana
    Kalunian, Kenneth C.
    Galateanu, Catrinel
    Bongardt, Sabine
    Stach, Christian
    Beaudot, Carolyn
    Kilgallen, Brian
    Gordon, Caroline
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 362 - 375
  • [38] Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Anca D. Askanase
    Enxu Zhao
    Julie Zhu
    Roman Bilyk
    Richard A. Furie
    Rheumatology and Therapy, 2021, 8 : 1915 - 1915
  • [39] Steroid-Sparing Effects of Methotrexate in Systemic Lupus Erythematosus: A Double-Blind, Randomized, Placebo-Controlled Trial
    Fortin, Paul R.
    Abrahamowicz, Michal
    Ferland, Diane
    Lacaille, Diane
    Smith, C. Douglas
    Zummer, Michel
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12): : 1796 - 1804
  • [40] Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus - A double-blind, randomized, placebo-controlled trial
    Petri, MA
    Lahita, RG
    van Vollenhoven, RF
    Merrill, JT
    Schiff, M
    Ginzler, EM
    Strand, V
    Kunz, A
    Gorelick, KJ
    Schwartz, KE
    ARTHRITIS AND RHEUMATISM, 2002, 46 (07): : 1820 - 1829
12345